Fingerprint
Dive into the research topics of 'A phase II randomized study of neoadjuvant letrozole plus alpelisib for hormone receptor-positive, human epidermal growth factor receptor 2-negative breast cancer (NeO-ORB)'. Together they form a unique fingerprint.- Sort by
- Weight
- Alphabetically